Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4635PDF: 1845HTML: 1133 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3492PDF: 1055HTML: 3037 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3893PDF: 991HTML: 6892 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1769HTML: 716PDF: 933 -
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1886PDF: 874HTML: 315 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1648PDF: 1036HTML: 271 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1623PDF: 879HTML: 381 -
-
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
2084PDF: 1136HTML: 270 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2154PDF: 2045HTML: 813
1 - 16 of 16 items







